Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FRESENIUS SE : Buy rating from JP Morgan

05/20/2021 | 04:38pm EDT

Already positive, the research from JP Morgan and its analyst David Adlington still consider the stock as a Buy opportunity. The target price remains set at EUR 50.


© MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS SE & CO. KGAA
07/30ADRs End Lower; IAG, Fresenius Among Companies Actively Trading
DJ
07/30DGAP-CMS : Fresenius Medical Care AG & Co. KGaA: Release according to Article 50..
DJ
07/30FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
07/30FRESENIUS SE : Credit Suisse sticks Neutral
MD
07/30Eurostoxx 50 : European shares slip but log sixth straight month of gains
RE
07/30European ADRs Drop Nearly 0.5% as Miners, Drillers Lag
MT
07/30FRESENIUS MEDICAL CARE : Healthcare group Fresenius raises 2021 forecasts
RE
07/30FRESENIUS SE : DZ Bank keeps its Buy rating
MD
07/30SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Friday
MT
07/30FRESENIUS : Conference Call Q2 2021 (PDF, 2.71 MB)
PU
More news
Financials
Sales 2021 37 181 M 44 123 M 44 123 M
Net income 2021 1 810 M 2 147 M 2 147 M
Net Debt 2021 22 406 M 26 590 M 26 590 M
P/E ratio 2021 13,7x
Yield 2021 1,87%
Capitalization 24 710 M 29 312 M 29 324 M
EV / Sales 2021 1,27x
EV / Sales 2022 1,15x
Nbr of Employees 310 842
Free-Float 73,1%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 44,32 €
Average target price 48,84 €
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter Müller Independent Member-Supervisory Board